Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Liesbeth Bieghs, Hans E. Johnsen, Ken Maes, Eline Menu, Els Van Valckenborgh, Michael T. Overgaard, Mette Nyegaard, Cheryl A. Conover, Karin Vanderkerken, Elke De Bruyne
Published Apr 25, 2016 · Vol. 7, No. 30 · pp. 48732-48752
Sonja Hesbacher, Lisa Pfitzer, Katharina Wiedorfer, Sabrina Angermeyer, Andreas Borst, Sebastian Haferkamp, Claus-Jürgen Scholz, Marion Wobser, David Schrama, Roland Houben
Published Apr 18, 2016 · Vol. 7, No. 22 · pp. 32956-32968
Thomas V. Guy, Alexandra M. Terry, Holly A. Bolton, David G. Hancock, Erhua Zhu, Robert Brink, Helen M. McGuire, Elena Shklovskaya, Barbara Fazekas de St Groth
Published Apr 18, 2016 · Vol. 7, No. 21 · pp. 30211-30229